细胞外基质市场：按成分类型、按应用、按来源、按最终用途、按产品类型、按技术、按治疗领域、按功能、按生物材料材料类型、按最终用途行业、按地区

细胞外基质市场规模预计将从 2023 年的 3,790 万美元增至 2030 年的 6,410 万美元，预测期内复合年增长率为 7.8%。

图 1. 2023 年细胞外基质市场占有率(%)（按地区）

细胞外基质（ECM）是指由蛋白质和碳水化合物组成的复杂网络，为组织和器官内的细胞提供结构支撑。它在控制细胞行为，包括细胞黏合、迁移、增殖和分化方面发挥重要作用。 ECM 也作为生长因子和细胞激素的储存库，影响各种细胞过程。由于慢性伤口数量的增加、人口高龄化和道路事故发生率的增加，预计未来几年全球细胞外基质市场规模将显着增长。源自人类/动物组织的细胞外基质可作为细胞迁移、增殖和组织组织的支架。透过刺激细胞增生、新血管和组织重塑来促进创伤治疗。 ECM 技术旨在重现适当的组织再生和功能所需的复杂结构和生化讯号。慢性伤口癒合方面令人鼓舞的临床结果以及对微创治疗方案的日益偏好可能会推动医疗保健产业对 ECM 产品的需求。

市场动态：

然而，市场面临诸如基于ECM的疗法的高成本、严格的监管要求和限制性报销政策等挑战。基于 ECM 的治疗方法的高成本是市场成长的主要障碍，限制了更多患者群体的使用。此外，某些地区对ECM产品核准的严格监管要求和有限的报销政策也阻碍了市场扩张。

此外，随着再生医学需求的增加，扩大新兴市场的产品系列可能会开闢新的市场成长途径。

总之，全球细胞外基质市场是由慢性病盛行率增加和再生医学需求增加等因素所推动的。然而，需要解决高成本和监管要求等挑战，同时需要利用新兴地区的技术创新和市场拓展等机会。

本研究的主要特点

• 本报告对全球细胞外基质市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
• 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
• 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务实绩和策略）来介绍全球虚拟医疗服务市场的主要企业。
• 该报告的见解使公司行销人员和负责人能够就未来的产品发布、经营团队升级、市场扩张和行销策略做出明智的资讯。
• 全球细胞外基质市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球细胞外基质市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目标
• 假设
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 慢性病盛行率增加
  • 抑制因素
• 基于 ECM 的治疗成本很高
  • 机会
• 开发基于 ECM 的创新产品
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章全球细胞外基质市场－冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球细胞外基质市场，依成分类型，2018-2030

• 蛋白质
• 糖蛋白
• 蛋白多醣
• 其他 ECM 分子

第六章全球细胞外基质市场，依应用分类，2018-2030

• 再生医学
• 人体组织工程
• 创伤治疗
• 药物输送
• 癌症研究
• 其他的

第 7 章 全球细胞外基质市场，依来源划分，2018-2030 年

• 动物源性ECM
• 人源ECM
• 合成ECM

第 8 章全球细胞外基质市场，依最终使用者划分，2018-2030 年

• 研究机构和学术中心
• 生物技术和製药公司
• 医院和诊所

第9章全球细胞外基质市场，依产品类型，2018-2030

• 水凝胶
• 鹰架
• 去细胞ECM
• ECM模拟
• 其他的

第 10 章 全球细胞外基质市场，依技术划分，2018-2030 年

• 3D生物列印
• 奈米科技
• 细胞培养技术
• 基因工程
• 其他的

第十一章全球细胞外基质市场，依治疗领域，2018-2030

• 整形外科
• 皮肤科
• 心臟病学
• 神经病学
• 肿瘤学
• 其他的

第十二章全球细胞外基质市场，依功能，2018-2030

• 结构支撑
• 蜂巢通讯
• 细胞黏合
• 讯号传导

第十三章全球细胞外基质市场，依生物材料材料类型，2018-2030

• 天然ECM
• 合成ECM

第 14 章全球细胞外基质市场，依最终用途产业划分，2018-2030 年

• 卫生保健
• 研究与开发
• 化妆品
• 药品
• 其他的

第十五章全球细胞外基质市场，按地区，2018-2030

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中东
• GCC
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第十六章竞争形势

• Thermo Fisher Scientific
• DSM
• Acelity（KCI Concepts）
• Corning Incorporated
• Baxter
• FUJIFILM Holdings Corporation
• Integra LifeSciences
• CellSystems Biotechnologie Vertrieb GmbH
• Biotime, Inc.
• Trevigen, Inc.
• Advanced BioMatrix
• Collagen Matrix, Inc.
• Merck KGaA
• VWR International LLC
• REPROCELL USA Inc.
• BioLamina AB
• Matricel GmbH
• Tissue Regenix
• Admedus
• MIMETAS

第十七章 节

• 调查方法
• 关于出版商

The extracellular matrix market size is expected to reach US$ 64.1 Mn by 2030, from US$ 37.9 Mn in 2023, at a CAGR of 7.8% during the forecast period.

Figure 1. Extracellular Matrix Market Share (%), By Region, 2023

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes. The global extracellular matrix market size is expected to grow significantly in the coming years due to rising incidences of chronic wounds, increasing aging population and growing incidence of road accidents. Extracellular matrix derived from human/animal tissues acts as a scaffold for cellular migration, proliferation and tissue organization. It promotes wound healing by stimulating cell proliferation, neovascularization and tissue remodeling. ECM technologies aim to recreate the complex structural and biochemical signals required for proper tissue regeneration and function. Promising clinical results in healing chronic wounds, combined with increasing preference for minimally invasive treatment options will boost demand for ECM products in the healthcare industry.

Market Dynamics:

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

• This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), with 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global virtual health service market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
• The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Extracellular Matrix Market Segmentation:

• By Component Type
  • Proteins
  • Glycoproteins
  • Proteoglycans
  • Other ECM molecules
• By Application:
  • Regenerative Medicine
  • Tissue Engineering
  • Wound Healing
  • Drug Delivery
  • Others
• By Source:
  • Animal-Derived ECM
  • Human-Derived ECM
  • Synthetic ECM
• By End-User:
  • Research Institutes and Academic Centers
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
• By Product Type:
  • Hydrogels
  • Scaffolds
  • Decellularized ECM
  • ECM Analogs
  • Others
• By Technology:
  • 3D Bioprinting
  • Nanotechnology
  • Cell Culture Techniques
  • Genetic Engineering
  • Others
• By Therapeutic Area:
  • Orthopedics
  • Dermatology
  • Cardiology
  • Neurology
  • Oncology
  • Others
• By Function:
  • Structural Support
  • Cellular Communication
  • Cell Adhesion
  • Signal Transduction
• By Biomaterial Type:
  • Natural ECM
  • Synthetic ECM
• By End-Use Industry:
  • Healthcare
  • Research and Development
  • Cosmetics
  • Pharmaceuticals
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top companies in Extracellular Matrix Market
  • Thermo Fisher Scientific
  • DSM
  • Acelity (KCI Concepts)
  • Corning Incorporated
  • Baxter
  • FUJIFILM Holdings Corporation
  • Integra LifeSciences
  • CellSystems Biotechnologie Vertrieb GmbH
  • Biotime, Inc.
  • Trevigen, Inc.
  • Advanced BioMatrix
  • Collagen Matrix, Inc.
  • Merck KGaA
  • VWR International LLC
  • REPROCELL USA Inc.
  • BioLamina AB
  • Matricel GmbH
  • Tissue Regenix
  • Admedus
  • MIMETAS

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Extracellular Matrix, By Component Type
  • Market Global Extracellular Matrix, By Application
  • Market Global Extracellular Matrix, By Source
  • Market Global Extracellular Matrix, By End-User
  • Market Global Extracellular Matrix, By Product Type
  • Market Global Extracellular Matrix, By Technology
  • Market Global Extracellular Matrix, By Therapeutic Area
  • Market Global Extracellular Matrix, By Function
  • Market Global Extracellular Matrix, By Biomaterial Type
  • Market Global Extracellular Matrix, By End-Use Industry
  • Market Global Extracellular Matrix, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• The increasing prevalence of chronic diseases
  • Restraints
• High cost of ECM-based therapies
  • Opportunities
• Development of innovative ECM-based products
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Extracellular Matrix Market , By Component Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2018 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Glycoproteins
• Proteoglycans
• Other ECM molecules

6. Global Extracellular Matrix Market , By Application, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Tissue Engineering
• Wound Healing
• Drug Delivery
• Cancer Research
• Others

7. Global Extracellular Matrix Market , By Source, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Animal-Derived ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Human-Derived ECM
• Synthetic ECM

8. Global Extracellular Matrix Market , By End-User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Research Institutes and Academic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Biotechnology and Pharmaceutical Companies
• Hospitals and Clinics

9. Global Extracellular Matrix Market , By Product Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hydrogels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Scaffolds
• Decellularized ECM
• ECM Analogs
• Others

10. Global Extracellular Matrix Market , By Technology, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• 3D Bioprinting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Nanotechnology
• Cell Culture Techniques
• Genetic Engineering
• Others

11. Global Extracellular Matrix Market , By Therapeutic Area, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Orthopedics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Dermatology
• Cardiology
• Neurology
• Oncology
• Others

12. Global Extracellular Matrix Market , By Function, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Structural Support
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Cellular Communication
• Cell Adhesion
• Signal Transduction

13. Global Extracellular Matrix Market , By Biomaterial Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Natural ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Synthetic ECM
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

14. Global Extracellular Matrix Market , By End-Use Industry, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Healthcare
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Research and Development
• Cosmetics
• Pharmaceuticals
• Others

15. Global Extracellular Matrix Market , By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Function, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
• GCC
• Israel
• Rest of Middle East
• Africa
• North Africa
• Central Africa
• South Africa

16. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DSM
• Acelity (KCI Concepts)
• Corning Incorporated
• Baxter
• FUJIFILM Holdings Corporation
• Integra LifeSciences
• CellSystems Biotechnologie Vertrieb GmbH
• Biotime, Inc.
• Trevigen, Inc.
• Advanced BioMatrix
• Collagen Matrix, Inc.
• Merck KGaA
• VWR International LLC
• REPROCELL USA Inc.
• BioLamina AB
• Matricel GmbH
• Tissue Regenix
• Admedus
• MIMETAS
• Analyst Views

17. Section

• Research Methodology
• About us